SCHEMBL24933239

SCHEMBL24933239

Brc1ccc(OCC2CN(CC3CC3)CCO2)cc1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 10/20 0.54
HRH3 Q9Y5N1 9/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15284947 0.80 DRD4 (0.73) DRD4HRH3
SCHEMBL15284941 0.80 DRD4 (0.73) DRD4HRH3
SCHEMBL27037489 0.77 TDP1 (0.47) DRD4
SCHEMBL24933231 0.73 PDK1 (0.57) DRD4HRH3
SCHEMBL1928209 0.73 RAB9A (0.54)
SCHEMBL6072643 0.72 SMN1; SMN2 (0.56)
SCHEMBL29203456 0.72 MAPK1 (0.50)
SCHEMBL17592769 0.70 TDP1 (0.66)
SCHEMBL1513424 0.70 TDP1 (0.66)
SCHEMBL1513422 0.70 TDP1 (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed